MIR8057

Across TCGA pan-cancer cohorts, MIR8057 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR8057 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR8057 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR8057 expression acts as an unfavorable survival marker, although some lineages such as LAML and PAAD show a favorable association.

KIRC, LAML, and PAAD are the cancer types where MIR8057 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.178	0.624	.007	54	view →
LAML	DFS	Tertile	All	0.590	0.245	<.001	48	view →
PAAD	OS	Tertile	All	1.000	0.375	.031	27	view →
SARC	DFS	Tertile	All	0.160	0.546	.011	18	view →
UCEC	DFS	Tertile	All	0.792	0.902	.011	18	view →
LIHC	OS	Tertile	II,III,IV	0.042	0.772	<.001	18	view →
GBM	OS	Tertile	All	0.166	0.416	.023	9	view →
COAD	DFS	Tertile	II,III,IV	0.074	0.744	<.001	9	view →
STAD	DFS	Tertile	All	0.503	0.666	.040	9	view →
THCA	DFS	Tertile	II,III,IV	0.427	0.774	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR8057–KIRC (DFS)

Open the KIRC breakdown →